UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Real‐world resource use and costs of haemophilia A‐related bleeding

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-07, Vol.23 (4), p.e267-e275

2017

Volltextzugriff (PDF)

Measurement properties of the Haem‐A‐QoL in haemophilia clinical trials

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-05, Vol.23 (3), p.383-391

2017

Volltextzugriff (PDF)

The changing costs of caring for Hemophilia Patients in the U.S.: insurers’ and patients’ perspectives

Value in health, 2015-05, Vol.18 (3), p.A304-A304

2015

Volltextzugriff (PDF)

Managed care Organization Budget impact of adding Recombinant Factor VIII FC fusion protein (RFVIIIFC) to the formulary for the treatment of Hemophilia A

Value in health, 2015-05, Vol.18 (3), p.A294-A294

2015

Volltextzugriff (PDF)

PRM56 Modeling the Progression of Chronic Diseases in a Dynamic Market: Implications for Budget Impact Analysis

Value in health, 2012-06, Vol.15 (4), p.A168-A168

2012

Volltextzugriff (PDF)

PCV14 Are Vasodilators of Value in the Care of Patients Hospitalized for Acute Heart Failure?

Value in health, 2012-06, Vol.15 (4), p.A114-A114

2012

Volltextzugriff (PDF)

PCV100 Acute Heart Failure Patients with and Without Renal Impairment: A Study of Heart Failure-Related Resource Utilization and Costs in the United States

Value in health, 2012-06, Vol.15 (4), p.A130-A130

2012

Volltextzugriff (PDF)

Treating acute heart failure in the elderly: A comparison of three inpatient treatment alternatives in the United States

Value in health, 2013-05, Vol.16 (3), p.A9-A9

2013

Volltextzugriff (PDF)

PCV102 Chronic Heart Failure in the Elderly: Costs and Resource Utilization Following Initial Hospitalizaton

Value in health, 2012-06, Vol.15 (4), p.A130-A131

2012

Volltextzugriff (PDF)

PCV99 MEDICAL RESOURCE UTILIZATION AND COSTS FOLLOWING HOSPITALIZATION OF PATIENTS WITH CHRONIC HEART FAILURE IN THE UNITED STATES

Value in health, 2011, Vol.14 (3), p.A50-A50

2011

Volltextzugriff (PDF)

SA74 A Systematic Literature Review to Assess the Level of Evidence in Facioscapulohumeral Muscular Dystrophy

Value in health, 2023-12, Vol.26 (12), p.S556

2023

Volltextzugriff (PDF)

P314 A systematic literature review to assess the level of evidence in facioscapulohumeral muscular dystrophy

Neuromuscular disorders : NMD, 2023-10, Vol.33, p.S122-S122

2023

Volltextzugriff (PDF)

C37 NEW INSIGHTS IN THE EPIDEMIOLOGY, MANAGEMENT, AND OUTCOMES OF CYSTIC FIBROSIS, ILD, AND RESPIRATORY DISEASE: Real-World Evidence On Adherence And Hospitalizations Following Treatment Initiation With 2 Newly Approved Medications For Idiopathic Pulmonary Fibrosis (ipf)

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

SA7 A Systematic Literature Review to Assess the Level of Evidence in Facioscapulohumeral Muscular Dystrophy

Value in health, 2023-06, Vol.26 (6), p.S398-S398

2023

Volltextzugriff (PDF)

EPH75 Applying Machine Learning (ML) to Estimate Prevalence of Facioscapulohumeral Muscular Dystrophy (FSHD) and Related Disease Burden: Findings From United States Claims Analysis

Value in health, 2022-12, Vol.25 (12), p.S205-S206

2022

Volltextzugriff (PDF)

PMH60 SURVEY OF PATIENT EXPERIENCE AND BURDEN OF ILLNESS IN WOMEN WITH POSTPARTUM DEPRESSION

Value in health, 2020-05, Vol.23, p.S211-S211

2020

Volltextzugriff (PDF)

PND74 THE HIGH BURDEN OF COMORBIDITIES AND TREATMENT CHANGES AMONG ADULTS WITH ESSENTIAL TREMOR IN A REAL-WORLD SETTING

Value in health, 2020-05, Vol.23, p.S273-S273

2020

Volltextzugriff (PDF)

PSY70 - The changing costs of caring for Hemophilia Patients in the U.S.: insurers’ and patients’ perspectives

Value in health, 2015-05, Vol.18 (3), p.A304-A304

2015

Volltextzugriff (PDF)

PMH2 BREXANOLONE INJECTION IN POSTPARTUM DEPRESSION: SUSTAINED REMISSION, SUSTAINED RESPONSE, AND NUMBER NEEDED TO TREAT

Value in health, 2019-11, Vol.22, p.S681-S681

2019

Volltextzugriff (PDF)

PMH51 BREXANOLONE INJECTION FOR THE TREATMENT OF POSTPARTUM DEPRESSION: MINIMAL IMPORTANT DIFFERENCE AND MEANINGFUL CHANGE

Value in health, 2019-11, Vol.22, p.S690-S690

2019

Volltextzugriff (PDF)

PSY18 - Managed care Organization Budget impact of adding Recombinant Factor VIII FC fusion protein (RFVIIIFC) to the formulary for the treatment of Hemophilia A

Value in health, 2015-05, Vol.18 (3), p.A294-A294

2015

Volltextzugriff (PDF)

PSY70 - Extended Half-Life Coagulation Factor IX In Haemophilia B Prophylaxis: A Cost-Effectiveness Analysis

Value in health, 2016-11, Vol.19 (7), p.A587-A587

2016

Volltextzugriff (PDF)

Extended Half-Life Coagulation Factor IX In Haemophilia B Prophylaxis: A Cost-Effectiveness Analysis

Value in health, 2016-11, Vol.19 (7), p.A587-A587

2016

Volltextzugriff (PDF)

155 Disease burden and healthcare resource utilisation among cutaneous lupus erythematosus patients with depression and/or anxiety; quantifying the unmet need

Lupus science & medicine, 2017-03, Vol.4 (Suppl 1), p.A71

2017

Volltextzugriff (PDF)

DB2 - A NEW METHOD FOR COUNTING HEMOPHILIA-RELATED BLEEDING EVENTS IN CLAIMS DATA

Value in health, 2015-05, Vol.18 (3), p.A2-A2

2015

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Englisch
(65)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Humans
(18)
Internal Medicine
(14)
Female
(11)
Adult
(10)
Male
(8)
Health Care Sciences & Services
(7)
Adolescent
(6)
Health Policy & Services
(6)
Postpartum Depression
(6)
Quality Of Life
(6)
Economics
(5)
Aged
(4)
Child
(4)
Children
(4)
Clinical Neurology
(4)
Cost-Benefit Analysis
(4)
Depression, Postpartum - Drug Therapy
(4)
General & Internal Medicine
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Real‐world resource use and costs of haemophilia A‐related bleeding

Measurement properties of the Haem‐A‐QoL in haemophilia clinical trials

The changing costs of caring for Hemophilia Patients in the U.S.: insurers’ and patients’ perspectives

Managed care Organization Budget impact of adding Recombinant Factor VIII FC fusion protein (RFVIIIFC) to the formulary for the treatment of Hemophilia A

PRM56 Modeling the Progression of Chronic Diseases in a Dynamic Market: Implications for Budget Impact Analysis

PCV14 Are Vasodilators of Value in the Care of Patients Hospitalized for Acute Heart Failure?

PCV100 Acute Heart Failure Patients with and Without Renal Impairment: A Study of Heart Failure-Related Resource Utilization and Costs in the United States

Treating acute heart failure in the elderly: A comparison of three inpatient treatment alternatives in the United States

PCV102 Chronic Heart Failure in the Elderly: Costs and Resource Utilization Following Initial Hospitalizaton

PCV99 MEDICAL RESOURCE UTILIZATION AND COSTS FOLLOWING HOSPITALIZATION OF PATIENTS WITH CHRONIC HEART FAILURE IN THE UNITED STATES

SA74 A Systematic Literature Review to Assess the Level of Evidence in Facioscapulohumeral Muscular Dystrophy

P314 A systematic literature review to assess the level of evidence in facioscapulohumeral muscular dystrophy

C37 NEW INSIGHTS IN THE EPIDEMIOLOGY, MANAGEMENT, AND OUTCOMES OF CYSTIC FIBROSIS, ILD, AND RESPIRATORY DISEASE: Real-World Evidence On Adherence And Hospitalizations Following Treatment Initiation With 2 Newly Approved Medications For Idiopathic Pulmonary Fibrosis (ipf)

SA7 A Systematic Literature Review to Assess the Level of Evidence in Facioscapulohumeral Muscular Dystrophy

EPH75 Applying Machine Learning (ML) to Estimate Prevalence of Facioscapulohumeral Muscular Dystrophy (FSHD) and Related Disease Burden: Findings From United States Claims Analysis

PMH60 SURVEY OF PATIENT EXPERIENCE AND BURDEN OF ILLNESS IN WOMEN WITH POSTPARTUM DEPRESSION

PND74 THE HIGH BURDEN OF COMORBIDITIES AND TREATMENT CHANGES AMONG ADULTS WITH ESSENTIAL TREMOR IN A REAL-WORLD SETTING

PSY70 - The changing costs of caring for Hemophilia Patients in the U.S.: insurers’ and patients’ perspectives

PMH2 BREXANOLONE INJECTION IN POSTPARTUM DEPRESSION: SUSTAINED REMISSION, SUSTAINED RESPONSE, AND NUMBER NEEDED TO TREAT

PMH51 BREXANOLONE INJECTION FOR THE TREATMENT OF POSTPARTUM DEPRESSION: MINIMAL IMPORTANT DIFFERENCE AND MEANINGFUL CHANGE

PSY18 - Managed care Organization Budget impact of adding Recombinant Factor VIII FC fusion protein (RFVIIIFC) to the formulary for the treatment of Hemophilia A

PSY70 - Extended Half-Life Coagulation Factor IX In Haemophilia B Prophylaxis: A Cost-Effectiveness Analysis

Extended Half-Life Coagulation Factor IX In Haemophilia B Prophylaxis: A Cost-Effectiveness Analysis

155 Disease burden and healthcare resource utilisation among cutaneous lupus erythematosus patients with depression and/or anxiety; quantifying the unmet need

DB2 - A NEW METHOD FOR COUNTING HEMOPHILIA-RELATED BLEEDING EVENTS IN CLAIMS DATA

Suchergebnisse filtern